Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Syros Pharmaceuticals Inc
About SYRS
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies. The Company is advancing Tamibarotene, a selective retinoic acid receptor alpha (RARα), agonist for which the Company is conducting SELECT-MDS-1, a Phase III clinical trial evaluating tamibarotene in combination with azacitidine in a genomically defined subset of patients with higher-risk myelodysplastic syndrome (HR-MDS), and for which it is conducting SELECT-AML-1, a randomized Phase II clinical trial evaluating tamibarotene in combination with venetoclax and azacitidine in a genomically defined subset of newly diagnosed patients with acute myeloid leukemia (AML). Its other assets include SY-2101 and SY-5609. The Company is seeking out-licensing opportunities for the further development of SY-5609, its highly selective and potent inhibitor of cyclin dependent kinase 7 (CDK7).
Find out what a historical investment in Syros Pharmaceuticals Inc would be worth today using our SYRS stock calculator.
Market Capitalisation
$5.37K
Price-earnings ratio
-
Dividend yield
0.00%
Volume
622
High today
$0.00
Low today
$0.00
Open price
$0.00
52-week high
$0.04
52-week low
$0.00
Ready to start your investing journey with Stake?
Open an accountHow do I buy SYRS shares in Australia?
Buying SYRS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Syros Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SYRS
What is the ticker symbol of Syros Pharmaceuticals Inc?
The ticker symbol for Syros Pharmaceuticals Inc is SYRS.
How much is one share of SYRS?
One share of SYRS is valued at $0.01 as of 20 May 2026.
What is the market capitalisation of Syros Pharmaceuticals Inc SYRS?
As of 20 May 2026 Syros Pharmaceuticals Inc has a market cap of $5.37K.
What is the 52-week high for Syros Pharmaceuticals Inc stock?
The Syros Pharmaceuticals Inc 52-week high stock price is $0.04.
What is the 52-week low for Syros Pharmaceuticals Inc stock?
The Syros Pharmaceuticals Inc 52-week low stock price is $0.00.
Can I buy SYRS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SYRS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SYRS on Stake
- Buy SYRS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SYRS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SYRS related stocks